Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

YOQNEAM, Israel and SAN RAMON, California, February 10 /PRNewswire/ --

NEW DELHI, India, February 9 /PRNewswire/ --

NEW YORK, February 8 /PRNewswire/ --

- Pace-Setting Company to Showcase Energy-Efficient LED Lamps and Lighting Solutions at Leading Event for Architectural, Retail and Commercial Lighting Professionals

Lighting Science Group Corporation (Lighting Science) (OTC Bulletin Board: LSCG), a global innovator in providing intelligent, pace-setting light-emitting diode (LED) lighting solutions, will exhibit at The ARC Show (booth M28) on Feb. 11-13th, 2008 in London. The company will showcase its range of environmentally sustainable and highly energy-efficient LED lighting solutions which have been featured in leading-edge architectural designs around the world.

MALVERN, Pennsylvania, February 8 /PRNewswire/ --

Safety of patients treated with Myobloc(R) (Botulinum Toxin Type B) Injectable Solution has always been of primary importance for Solstice Neurosciences, Inc. ("Solstice"). We support education and training of physicians in a number of ways regarding the proper use of this product as outlined in the prescribing information.

We maintain a rigorous and routine process for monitoring and reporting any adverse events to regulatory authorities in compliance with all applicable regulations.

LONDON, February 8 /PRNewswire/ -- NHS Choices (http://www.nhs.uk), the online 'front door' to the NHS, launches a daily health news service to help people make sense of the stories appearing in the news about medical research.

Behind the headlines, on NHS Choices (http://www.nhs.uk/News/Pages/NewsIndex.aspx), is an evidence-based analysis of health stories that make the news. The service explains the facts behind newspaper headlines and an understanding of the science. It also provides an authoritative resource for General Practitioners, which they can rely on when talking to patients, and a trusted resource for journalists.

LONDON, February 8 /PRNewswire/ -- ALK Technologies today announced that customers of its award-winning CoPilot Live mobile phone navigation system will be able to benefit from an integral connection to Microsoft's Live Search(TM) API.

Simply key-in a search query into a free-text input box, for example 'bank', 'coffee' or a favoured brand, and a list of the matches closest to the current location is displayed. It's a significant enhancement to CoPilot's on-board address and points of interest search, providing access to a huge variety of dynamic real-time information.